Green tea as an effective antimicrobial for urinary tract infections caused by Escherichia coli

Frontiers in Microbiology

Volumn 4, Issue JUN, 2013, Pages

  Reygaert, Wanda ^a   Jusufi, Ilir ^b  

^a OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

Antimicrobial; Antimicrobial resistance; Escherichia coli; Green tea; Urinary tract infections

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; CEFAZOLIN; CEFEPIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; GREEN TEA EXTRACT; NITROFURANTOIN; NORFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TETRACYCLINE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; TEA; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

CAMELLIA SINENSIS; ESCHERICHIA COLI;

EID: 84882943803     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2013.00162     Document Type: Article

References (45)

1. Anderson, G. G., Dodson, K. W., Hooton, T. M., and Hultgren, S. J. (2004a). Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis. Trends Microbiol. 12, 424-430. doi: 10.1016/j.tim.2004.07.005
2. Anderson, G. G., Martin, S. M., and Hultgren, S. J. (2004b). Host subversion by formation of intracellular bacterial communities in the urinary tract. Microbes Infect. 6, 1094-1101. doi: 10.1016/j.micinf.2004.05.023
3. Cabrera, C., Artacho, R., and Giménez, R. (2006). Beneficial effects of green tea - a review. J. Am. Coll. Nutr. 25, 79-99.
4. Carson, C., and Naber, K. G. (2004). Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections. Drugs 64, 1359-1373. doi: 10.2165/00003495-200464120-00007
5. Chacko, S. M., Thambi, P. T., Kuttan, R., and Nishigaki, I. (2010). Beneficial effects of green tea: a literature review. Chin. Med. 5, 13. doi: 10.1186/1749-8546-5-13
6. Cho, Y. S., Schiller, N. L., Kahng, H. Y., and Oh, K. H. (2007). Cellular responses and proteomic analysis of Escherichia coli exposed to green tea polyphenols. Curr. Microbiol. 55, 501-506. doi: 10.1007/s00284-007-9021-8
7. Dias, R. C. S., Marangoni, D. V., Smith, S. P., Alves, E. M., Pellegrino, F. L. P. C., Riley, L. W. et al. (2009). Clonal composition of Escherichia coli causing community-acquired urinary tract infections in the State of Rio de Janeiro, Brazil. Microb. Drug Resist. 15, 303-308. doi: 10.1089/mdr.2009.0067
8. Friedman, M. (2007). Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas. Mol. Nutr. Food Res. 51, 116-134. doi: 10.1002/mnfr.200600173
9. George, D. B., and Manges, A. R. (2010). A systematic review of outbreak and non-outbreak studies of extraintestinal pathogenic Escherichia coli causing community-acquired infections. Epidemiol. Infect. 138, 1679-1690. doi: 10.1017/S0950268810001639
10. Gradišar, H., Pristovšek, P., Plaper, A., and Jerala, R. (2007). Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site. J. Med. Chem. 50, 264-271. doi: 10.1021/jm0608170
11. Gündoǧdu, A., Long, Y. B., Vollmerhausen, T. L., and Katouli, M. (2011). Antimicrobial resistance and distribution of sul genes and integron-associated intl genes among uropathogenic Escherichia coli in Queensland, Australia. J. Med. Microbiol. 60(Pt 11), 1633-1642. doi: 10.1099/jmm.0.034140-0
12. Jadhav, S., Hussain, A., Devi, S., Kumar, A., Parveen, S., Gandham, N., et al. (2011). Virulence characteristics and genetic affinities of multiple drug resistant uropathogenic Escherichia coli from a semi urban locality in India. PLoS ONE 6:e18063. doi: 10.1371/journal.pone.0018063
13. Kahlmeter, G. (2003). Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. Int. J. Antimicrob. Agents 22(Suppl. 2), 49-52. doi: 10.1016/S0924-8579(03)00229-2
14. Kaper, J. B., Nataro, J. P., and Mobley, H. L. T. (2004). Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2, 123-140. doi: 10.1038/nrmicro818
15. Karlowsky, J. A., Kelly, L. J., Thornsberry, C., Jones, M. E., and Sahm, D. F. (2002). Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob. Agents Chemother. 46, 2540-2545. doi: 10.1128/AAC.46.8.2540-2545.2002
16. Kau, A. L., Hunstad, D. A., and Hultgren, S. J. (2005). Interaction of uropathogenic Escherichia coli with host uroepithelium. Curr. Opin. Microbiol. 8, 54-59. doi: 10.1016/j.mib.2004.12.001
17. Kucheria, R., Dasgupta, P., Sacks, S. H., Khan, M. S., and Sheerin, N. S. (2005). Urinary tract infections: new insights into a common problem. Postgrad. Med. J. 81, 83-86. doi: 10.1136/pgmj.2004.023036
18. Landgren, M., Odén, H., Kühn, I., Osterland, A., and Kahlmeter, G. (2005). Diversity among 2481 Escherichia coli from women with community-acquired lower urinary tract infections in 17 countries. J. Antimicrob. Chemother. 55, 928-937.
19. Lee, M. J., Maliakal, P., Chen, L., Meng, X., Bondoc, F. Y., Prabhu, S., et al. (2002). Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomarkers Prev. 11(Pt 1), 1025-1032.
20. Li, D., Liu, B., Chen, M., Guo, D., Guo, X., Liu, F., et al. (2010). A multiplex PCR method to detect 14 Escherichia coli serogroups associated with urinary tract infections. J. Microbiol. Methods 82, 71-77. doi: 10.1016/j.mimet.2010.04.008
21. Luo, H., Tang, L., Tang, M., Billam, M., Huang, T., Yu, J., et al. (2006). Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine. Carcinogenesis 27, 262-268. doi: 10.1093/carcin/bgi147
22. Mak, J. C. (2012). Potential role of green tea catechins in various disease therapies: progress and promise. Clin. Exp. Pharmacol. Physiol. 39, 265-273. doi: 10.1111/j.1440-1681.2012.05673.x
23. Marrs, C. F., Zhang, L., and Foxman, B. (2005). Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes? FEMS Microbiol. Lett. 252, 183-190. doi: 10.1016/j.femsle.2005.08.028
24. McKay, D. L., and Blumberg, J. B. (2002). The role of tea in human health: an update. J. Am. Coll. Nutr. 21, 1-13.
25. Molina-López, J., Aparicio-Ozores, G., Ribas-Aparicio, R. M., Gavilanes-Parra, S., Chávez-Berrocal, M. E., Hernández-Castro, R., et al. (2011). Drug resistance, serotypes, and phylogenetic groups among uropathogenic Escherichia coli including O25-ST131 in Mexico City. J. Infect. Dev. Ctries. 5, 840-849. doi: 10.3855/jidc.1703
26. Muratani, T., and Matsumoto, T. (2004). Bacterial resistance to antimicrobials in urinary isolates. Int. J. Antimicrob. Agents 24(Suppl. 1), S28-S31. doi: 10.1016/j.ijantimicag.2004.02.001
27. National Institute of Diabetes and Digestive and Kidney Diseases. (2005). Urinary Tract Infection in Adults. Publication No. 06-2097. Bethesda, MD: National Kidney and Urologic Diseases Information Clearinghouse, National Institutes of Health.
28. Neyestani, T. R., Khalaji, N., and Gharavi, A. (2007). Selective microbiologic effects of tea extract on certain antibiotics against Escherichia coli in vitro. J. Altern. Complement. Med. 13, 1119-1124. doi: 10.1089/acm.2007.7033
29. Oliveira, F. A., Paludo, K. S., Arend, L. N. V. S., Farah, S. M. S. S., Pedrosa, F. O., Souza, E. M., et al. (2011). Virulence characteristics and antimicrobial susceptibility of uropathogenic Escherichia coli strains. Genet. Mol. Res. 10, 4114-4125. doi: 10.4238/2011.October.31.5
30. Pichon, C., Héchard, C., Du Merle, L., Chaudray, C., Bonne, I., Guadagnini, S., et al. (2009). Uropathogenic Escherichia coli AL511 requires flagellum to enter renal collecting duct cells. Cell Microbiol. 11, 616-628. doi: 10.1111/j.1462-5822.2008.01278.x
31. Sahm, D. F., Thornsberry, C., Mayfield, D. C., Jones, M. E., and Karlowsky, J. A. (2001). Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob. Agents Chemother. 45, 1402-1406. doi: 10.1128/AAC.45.5.1402-1406.2001
32. Schaeffer, A. J., Klumpp, D. J., Weiser, A. C., Sengupta, S., Forrestal, S. G., and Batler, R. A. (2004). Infectious response to E. coli: molecular and genetic pathways. Int. J. Antimicrob. Agents 24S, S57-S60. doi: 10.1016/j.ijantimicag.2004.02.011
33. Song, J. M., and Seong, B. L. (2007). Tea catechins as a potential alternative anti-infectious agent. Expert Rev. Anti. Infect. Ther. 5, 497-506. doi: 10.1586/14787210.5.3.497
34. Stenutz, R., Weintraub, A., and Widmalm, G. (2006). The structures of Escherichia coli O-polysaccharide antigens. FEMS Microbiol. Rev. 30, 382-403. doi: 10.1111/j.1574-6976.2006.00016.x
35. Taguri, T., Tanaka, T., and Kouno, I. (2004). Antimicrobial activity of 10 different plant polyphenols against bacteria causing food-borne disease. Biol. Pharm. Bull. 27, 1965-1969. doi: 10.1248/bpb.27.1965
36. Taguri, T., Tanaka, T., and Kouno, I. (2006). Antibacterial spectrum of plant polyphenols and extracts depending upon hydroxyphenyl structure. Biol. Pharm. Bull. 29, 2226-2235. doi: 10.1248/bpb.29.2226
37. Taylor, P. W., Hamilton-Miller, J. M. T., and Stapleton, P. D. (2005). Antimicrobial properties of green tea catechins. Food Sci. Technol. Bull. 2, 71-81.
38. Vosti, K. L. (2007). A prospective, longitudinal study of the behavior of serologically classified isolates of Escherichia coli in women with recurrent urinary tract infections. J. Infect. 55, 8-18. doi: 10.1016/j.jinf.2007.01.006
39. Vuong, Q. V., Nguyen, V., Golding, J. B., and Roach, P. D. (2011). The content of bioactive constituents as a quality index for Vietnamese teas. Int. Food Res. J. 18, 329-336.
40. Wagenlehner, F. M., and Naber, K. G. (2005). Fluoroquinolone antimicrobial agents in the treatment of prostatitis and recurrent urinary tract infections in men. Curr. Infect. Dis. Rep. 7, 9-16. doi: 10.1007/s11908-005-0018-9
41. Wang, Y., and Ho, C. T. (2009). Polyphenolic chemistry of tea and coffee: a century of progress. J. Agric. Food. Chem. 57, 8109-8114. doi: 10.1021/jf804025c
42. Warren, J. W., Abrutyn, E., Hebel, J. R., Johnson, J. R., Schaeffer, A. J., and Stamm, W. E. (1999). Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin. Infect. Dis. 29, 745-758. doi: 10.1086/520427
43. Yam, T. S., Shah, S., and Hamilton-Miller, J. M. T. (1997). Microbial activity of whole and fractionated crude extracts of tea (Camellia sinensis), and of tea components. FEMS Microbiol. Lett. 152, 169-174. doi: 10.1111/j.1574-6968.1997.tb10424.x
44. Yang, C. S., Chen, L., Lee, M. J., Balentine, D., Kuo, M. C., and Schantz, S. P. (1998). Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev. 7, 351-354.
45. Zhanel, G. G., Hisanaga, T. L., Laing, N. M., DeCorby, M. R., Nichol, K. A., Weshnoweski, B., et al. (2006). Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int. J. Antimicrob. Agents 27, 468-475. doi: 10.1016/j.ijantimicag.2006.02.009